Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus

Journal of Clinical Investigation

Volumn 101, Issue 10, 1998, Pages 2036-2041

  Forst, Thomas ^a   Kunt, Thomas ^a   Pohlmann, Thomas ^a   Goitom, Kbrum ^a   Engelbach, Martin ^a   Beyer, Jürgen ^a   Pfützner, Andreas ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Microvascular complications; Nutritive capillary blood flow; Tissue nutrition; Total skin blood flow

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; PLASMA PROTEIN;

ADULT; ARTERIOVENOUS SHUNT; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS DRUG ADMINISTRATION; LASER DOPPLER FLOWMETRY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SKIN BLOOD FLOW; SKIN TEMPERATURE;

EID: 0032523926     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2147     Document Type: Article

References (53)

1. Tooke, J.E. 1995. Microvascular function in human diabetes. Diabetes. 44:721-726.
2. Rendell, M., and B.S. Ola Bemisedun. 1992. Diabetic cutaneous microangiopathy. Am. J. Med. 93:611-618.
3. Shami, S.K., and S.J. Chittenden. 1991. Microangiopathy in diabetes mellitus. II. Features complications and investigation. Diabetes Research. 17:157-168.
4. Tooke, J.E., P.E. Lins, J. Ostergren, and B. Fagrell. 1985. Skin microvascular autoregulatory responses in type 1 diabetes: the influence of duration and control. Int. J. Microcirc. Clin. Exp. 4:249-256.
5. Ewald, U., T. Tuvemo, and G. Rooth. 1981. Early reduction of vascular reactivity in diabetic children detected by transcutaneous oxygen electrode. Lancet. I:1287-1288.
6. Flynn, M.D., and J.E. Tooke. 1992. Aetiology of diabetic foot ulceration: a role for the microcirculation? Diabetic Med. 8:320-329.
7. Smits, P., J.A. Kapma, M.C. Jacobs, J. Luttermann, and T. Thien. 1993. Endothelium-dependent vascular relaxation in patients with type 1 diabetes. Diabetes. 42:148-153.
8. Panza, J.A., A.A. Quyyumi, J.E. Brush, and S.E. Epstein. 1990. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 323:22-27.
9. McNally, P.G., P.A.C. Watt, T. Rimmer, A.C. Burden, J.R. Hearnshaw, and H. Thurston. 1994. Impaired contraction and endothelium dependent relaxation in isolated resistance vessels from patients with insulin-dependent diabetes mellitus. Clin. Sci. 87:31-36.
10. Watkins, P.J., and M.E. Edmonds. 1983. Sympathetic nerve failure in diabetes. Diabetologia. 25:73-77.
11. Stevens, M.J., M.E. Edmonds, A.V.M. Foster, S.L.E. Douglas, and P.J. Watkins. 1992. Paradoxical blood flow responses in the diabetic neuropathic foot: an assessment of the contribution of vascular denervation and microangiopathy. Diabetic Med. 9:49-54.
12. Coffmann, J.D. 1972. Total and nutritive blood flow in the finger. Clin. Sci. 42:243-250.
13. Jörneskog, G., K. Brismar, and B. Fagrell. 1995. Skin capillary circulation is more impaired in the toes of diabetic than non-diabetic patients with peripheral vascular disease. Diabetic Med. 12:36-41.
14. Jörneskog, G., K. Brismar, and B. Fagrell. 1995. Skin capillary circulation severely impaired in toes of patients with IDDM, with and without late diabetic complications. Diabetologia. 38:474-480.
15. Boulton, A.J.M., J.H.B. Scarpello, and J.D. Ward. 1982. Venous oxygenation in the diabetic neuropathic foot; evidence of arteriovenous shunting? Diabetologia. 22:6-8.
16. Johansson, B.L., B. Linde, and J. Wahren. 1992. Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia. 35:1151-1158.
17. Ido, Y., A. Vindigni, K. Chang, L. Stramm, R. Chance, W.F. Heath, R.D. DiMarchi, E. Di Cera, and J.R. Williamson. 1997. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science. 277:563-566.
18. Wahren, J., B.L. Johansson, and H. Wallberg-Henriksson. 1994. Does C-peptide have a physiological role? Diabetologia. 37(Suppl. 2):99-107.
19. Johansson, B.L., K. Borg, E. Fernqvist-Forbes, T. Odergren, S. Remahl, and J. Wahren. 1996. C-peptide improves autonomie nerve function in IDDM patients. Diabetologia. 39:687-695.
20. Johansson, B.L., A. Kernell, S. Sjöberg, and J. Wahren. 1993. Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J. Clin. Endocrinol. Metab. 77:976-981.
21. Ziegler, D., G. Laux, K. Dannehl, M. Spüler, H. Mühlen, P. Mayer, and F. A. Gries. 1992. Assessment of cardiovascular autonomie function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure response. Diabetic Med. 9: 166-175.
22. Claus, D., C. Mustafa, W. Vogel, M. Herz, and B. Neundörfer. 1993. Assessment of diabetic neuropathy: definition of norm and discrimination of abnormal nerve function. Muscle Nerve. 16:757-768.
23. Rendell, M., T. Bergmann, G. O'Donnell, E.D. Drobny, J. Borgos, and R.F. Bonner. 1989. Microvascular blood flow, volume, and velocity measured by laser Doppler techniques in IDDM. Diabetes. 38:819-824.
24. Bircher, A., E.M. de Boer, T. Agner, J.E. Wahlberg, and J. Serup. 1994. Guidelines for measurement of cutaneous blood flow by laser Doppler flowmetry. Contact Dermatitis. 30:65-72.
25. Forst, T., A. Pfützner, M. Arin, R. Bauersachs, B. Bach, H. Biehlmaier, E. Küstner, and J. Beyer. 1997. Effect of transcutaneous electrical nerve stimulation on total skin microcirculation in the diabetic foot. J. Diabetic Complications. 11:291-297.
26. Tooke, J.E. 1993. Methodologies used in the study of the microcirculation in diabetes mellitus. Diabetes Metab. Rev. 9:57-70.
27. Morgan, C.R., and A. Lazarow. 1963. Immunoassay for insulin: two antibody system. Plasma insulin levels in normal, subdiabetic and diabetic rats. Diabetes. 12:115-119.
28. Corbin, D.O.C., R.J. Young, D.C. Morrison, P. Hoskins, W.N. McDicken, E. Housley, and B.F. Clarke. 1987. Blood flow in the foot, polyneuropathy and foot ulceration in diabetes mellitus. Diabetologia. 30:468-473.
29. Flynn, M.D., M.E. Edmonds, J.E. Tooke, and P.J. Watkins. 1988. Direct measurement of capillary blood flow in the diabetic neuropathic foot. Diabetologia. 31:652-656.
30. Bollinger, A., J. Frey, K. Jäger, J. Furrer, J. Seglias, and W. Siegenthaler. 1982. Patterns of diffusion through skin capillaries in patients with long term diabetes. N. Engl. J. Med. 307:1305-1310.
31. Walmsley, D., and P.G. Wiles. 1991. Early loss of neurogenic inflammation in the human diabetic foot. Clin. Sci. 80:605-610.
32. Netten, P.M., H. Wollersheim, T. Thien, and J.A. Luttermann. 1996. Skin microcirculation of the foot in diabetic neuropathy. Clin. Sci. 91:559-565.
33. Rayman, G., S.A. Williams, P.D. Spencer, L.H. Smaje, P.M. Wise, and J.E. Tooke. 1986. Impaired microvascular hyperaemic response to minor skin trauma in type I diabetes. Clin. Res. 292:1295-1298.
34. Stansberry, K.B., S.A. Shapiro, M.A. Hill, P.M. McNitt, M.D. Meyer, and A.I. Vinik. 1996. Impaired peripheral vasomotion in diabetes. Diabetes Care. 19:715-721.
35. Benbow, S.J., D.W. Pryce, K. Noblett, I.A. MacFarlane, P.S. Friedmann, and G. Williams. 1995. Flow motion in peripheral diabetic neuropathy. Clin. Sci. 88:191-196.
36. Sandemann, D.D., A.C. Shore, and J.E. Tooke. 1992. Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control. N. Engl. J. Med. 327:760-764.
37. Rayman, G., R.A. Malik, A.K. Sharma, and J.L. Day. 1995. Microvascular response to tissue injury and capillary ultrastructure in the foot skin of type I diabetic patients. Clin. Sci. 89:467-474.
38. Jorneskog, G., J. Östergren, G. Tyden, J. Bolinder, and B. Fagrell. 1987. Is skin microvasculature reactivity improved in diabetes after pancreas and kidney transplantation? Int. J. Microcirc. Clin. Exp. 43:203-210.
39. Jörneskog, G., G. Tyden, J. Bolinder, and B. Fagrell. 1990. Does combined kidney and pancreas transplantation reverse functional diabetic microangiopathy? Transplant. Int. 3:167-170.
40. Sjöberg, S., R. Gunnarsson, M. Gjötterberg, M. Persson, and J. Östman. 1987. Residual insulin production and prevalence of microvascular lesions and polyneuropathy in long term type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 30:208-213.
41. Kernell, A., J. Ludvigsson, and K. Finnström. 1990. Vitreous fluorophotometry in juvenile diabetics with and without retinopathy in relation to metabolic control: insulin antibodies and C-peptide levels. Acta Ophthalmolgica. 68: 415-420.
42. Jörneskog, G., G. Tyden, J. Bolinder, and B. Fagrell. 1991. Skin microvascular reactivity in fingers of diabetic patients after combined kidney and pancreas transplantation. Diabetologia. 34(Suppl. 1):135-137.
43. Partanen, J., L. Niskanen, J. Lehtinen, E. Mervaala, O. Sitonen, and M. Uusitupa. 1995. Natural history of peripheral neuropathy in patients with non-insulin dependent diabetes mellitus. N. Engl. J. Med. 333:89-94.
44. Johansson, B.L., S. Sjöberg, and J. Wahren. 1992. The influence of human C-peptide on renal function and glucose utilisation in type 1 (insulin dependent) diabetic patients. Diabetologia. 35:121-128.
45. Hoogwerf, B.J., J.J. Barbosa, J.P. Bantle, D. Daine, and F.C. Goetz. 1983. Urinary C-peptide as a measure of beta cell function after a mixed meal in healthy subjects: comparison of four hour urine C-peptide with serum insulin and plasma C-peptide. Diabetes Care. 6:488-492.
46. Horwitz, D.L., J.I. Starr, M.E. Mako, W.G. Blackard, and A.H. Kubenstein. 1975. Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood, J. Clin. Invest. 55:1278-1283.
47. Flatt, P.R., S.K. Swanstonn-Flatt, S.M. Hampton, C.J. Bailey, and V. Marks. 1986. Specific binding of the C-peptide of proinsulin to cultured B-cells from a transplantable rat islet cell tumor. Biosci. Rep. 6:193-199.
48. +-ATPase activity in synergism with neuropeptide Y. Diabetologia. 39:199-205.
49. Greene, D.A., S.A. Lattimer, and A.A.F. Sima. 1987. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N. Engl. J. Med. 316:599-600.
50. +-ATPase in the pathogenesis of human diabetic neuropathy. J. Neuroi Sci. 120:159-167.
51. Tooke, J.E., P.E. Lins, J. Östergren, U. Adamson, and B. Fagrell. 1985. The effect of intravenous insulin infusion on skin microcirculatory flow in type 1 diabetes. Int. J. Microcirc. 4:69-83.
52. Flynn, M.D., M. Boolell, J.E. Tooke, and P.J. Watkins. 1992. The effect of insulin infusion on capillary blood flow in the diabetic neuropathic foot. Diabetic Med. 9:630-634.
53. Poldermann, K.H., C.D.A. Stehhouwer, G.J. van Kamp, and L.J.G. Gooren. 1996. Effects of insulin infusion on endothelium-derived vasoactive substances. Diabetologia. 39:1284-1292.